,i  #aahth ,,congress  #b;d ,session    
,h4 ,r4 #hjfe  ,,in ,,the ,,house ,,of  
,,representatives  ,april #ah1 #bjbd,mr4
 ,costa 7for himself and ,mr4 ,kiley7   
introduced the following bill2 which was
 referred to the ,committee on ,energy  
and ,commerce  ,a ,,bill  ,to require   
the ,secretary of ,health and ,human    
,services1 acting through the ,assistant
 ,secretary for ,preparedness and       
,response1 to carry out a program under 
which the ,secretary requires each      
regulated seller of a highly infectious 
agent to comply with certain logbook    
requirements1 and for other purposes4   
#a4 ,short title ,this ,act may be cited
 as the ,preventing ,illegal            
,laboratories and ,protecting ,public   
,health ,act of #bjbd4  #b4 ,requiring  
certain sellers of highly infectious    
agents ,to keep a logbook of sales  7a7 
,program ,the ,secretary of ,health and 
,human ,services1 acting through the    
,assistant ,secretary for ,preparedness 
and ,response1 shall carry out a program

 under which the ,secretary requires    
each regulated seller of a highly       
infectious agent to comply with the     
logbook requirements of subsection 7c74 
7b7 ,list of highly infectious agents   
7#a7 ,development ,the ,secretary shall 
develop and maintain a list of all      
agents that meet the definition of a    
highly infectious agent in subsection   
7e74  7#b7 ,initial list ,the ,secretary
 shall develop the initial list required
 by paragraph 7#a7 not later than #ab   
months after the date of enactment of   
this ,act4  7#c7 ,periodic review ,the  
,secretary shall periodically review and
 update the list required by paragraph  
7#a74  7#d7 ,consultation2 consideration
 ,in developing and updating the list   
required by paragraph 7#a71 the         
,secretary shall--  7,a7 consult with   
relevant agencies1 including the        
,centers for ,disease ,control and      
,prevention1 the ,national ,institutes  
of ,health1 and the ,department of      
,homeland ,security2  7,b7 take into    

consideration the latest edition of     
,biosafety in ,microbiological and      
,biomedical ,laboratories published by  
the ,centers for ,disease ,control and  
,prevention and the ,national           
,institutes of ,health 7or any successor
 to such publication72 and  7,c7 take   
into consideration the latest edition of
 ,,nih ,guidelines for ,research        
,involving ,recombinant or ,synthetic   
,nucleic ,acid ,molecules published by  
the ,national ,institutes of ,health 7or
 any successor to such publication74    
7c7 ,logbook requirements  7#a7 ,in     
general ,each regulated seller shall    
maintain1 in accordance with criteria   
issued by the ,secretary1 an electronic 
list 7in this section referred to as a  
logbook7 of the sales by such seller of 
each highly infectious agent on the list
 under subsection 7b7 that identifies-- 
7,a7 the agent by name2  7,b7 the       
quantity sold2  7,c7 the name and       
address of each purchaser1 including    
relevant identifying business           

information as deemed necessary by the  
,secretary2  7,d7 a short description of
 the purchaser's intended use of the    
agent2 and  7,e7 the date and time of   
the sale4  7#b7 ,sale requirements ,in  
the case of a sale to which the         
requirement of paragraph 7#a7 applies1  
the regulated seller shall not sell the 
highly infectious agent unless-- 7,a7   
the prospective purchaser--  7i7        
presents an identification card that    
provides a photograph and is issued by a
 ,state or the ,federal ,government1 or 
a document that1 with respect to        
identification1 is considered acceptable
 for purposes of sections               
#bgd;a4#b7;b77#a77v77,a7 and            
#bgd;a4#b7;b77#a77v77,b7 of title #h1   
,code of ,federal ,regulations 7or      
successor regulations72 and  7ii7 signs 
the logbook and enters in the logbook-- 
7,i7 the purchaser's name and address2  
7,,ii7 a short description of the       
purchaser's intended use of the agent2  
and  7,,iii7 the date and time of the   

sale2 and  7,b7 the regulated seller--  
7i7 determines that the name entered in 
the logbook corresponds to the name     
provided on such identification and that
 the date and time entered are correct2 
and  7ii7 enters in the logbook the name
 of the highly infectious agent and the 
quantity sold4  7#c7 ,contents ,the     
regulated seller shall include in the   
logbook1 in accordance with criteria of 
the ,secretary1 a notice to purchasers  
that entering false statements or       
misrepresentations in the logbook may   
subject the purchasers to criminal      
penalties under section #ajja of title  
#ah1 ,united ,states ,code1 which notice
 specifies the maximum fine and term of 
imprisonment under such section4  7#d7  
,duration of maintenance of entries ,the
 regulated seller shall maintain each   
entry in the logbook for not fewer than 
five years after the date on which the  
entry is made4  7#e7 ,disclosure of     
logbooks ,the ,secretary shall establish
 restrictions on disclosure of          

information in logbooks4 ,such          
regulations shall-- 7,a7 provide for the
 disclosure of the information as       
appropriate to the ,secretary and to    
,federal1 ,state1 and local law         
enforcement agencies2 and  7,b7 prohibit
 accessing1 using1 or sharing           
information in the logbooks for any     
purpose other than to ensure compliance 
with this section or to protect public  
health and safety4  7d7 ,false          
statements or misrepresentations by     
purchasers ,for purposes of section     
#ajja of title #ah1 ,united ,states     
,code1 entering information in a logbook
 shall be considered a matter within the
 jurisdiction of the executive1         
legislative1 or judicial branch of the  
,government of the ,united ,states4  7e7
 ,definitions ,in this section3 7#a7    
,the term highly infectious agent means 
an infectious agent that meets the      
criteria of risk group #c or risk group 
#d as such risk groups are defined in   
the latest edition of ,,nih ,guidelines 

for ,research ,involving ,recombinant or
 ,synthetic ,nucleic ,acid ,molecules   
published by the ,national ,institutes  
of ,health 7or any successor to such    
publication74  7#b7 ,the term regulated 
seller means a seller of highly         
infectious agents1 except that such term
 does not include an employee or agent  
of such a seller4  7#c7 ,the term       
,secretary means the ,secretary of      
,health and ,human ,services1 acting    
through the ,assistant ,secretary for   
,preparedness and ,response4  #c4       
,evaluation of high-containment         
laboratories  7a7 ,in general ,the      
,national ,security ,advisor1 in        
consultation with the ,secretary of     
,health and ,human ,services1 the       
,secretary of ,agriculture1 the         
,secretary of ,defense1 the ,secretary  
of ,homeland ,security1 the ,national   
,intelligence ,council1 and such other  
,federal officials as the ,national     
,security ,advisor determines           
appropriate1 shall identify a single    

,federal official to oversee a periodic 
strategic evaluation of high-containment
 laboratories in the ,united ,states4   
7b7 ,topics ,each strategic evaluation  
under subsection 7a7 shall include--    
7#a7 an assessment of-- 7,a7 the number1
 location1 and mission of               
high-containment laboratories2  7,b7 the
 capacity of such existing laboratories 
to effectively meet national goals to   
counter threats to biosafety and        
biosecurity2  7,c7 the aggregate risks  
associated with--  7i7 such existing    
laboratories2 and  7ii7 expanding the   
numbers and facilities of such          
laboratories2 and  7,d7 the type of     
oversight needed for high-containment   
laboratories2 and  7#b7 up-to-date      
national standards1 developed by the    
,federal official designated under      
subsection 7a7 in consultation with the 
scientific community1 for the design1   
construction1 commissioning1 operation1 
and long-term maintenance of            
high-containment laboratories4  7c7     

,reporting ,upon completion of each     
strategic evaluation under subsection1  
7a71 the ,federal official designated   
under subsection 7a7 shall submit to the
 ,president and the ,congress a report  
on the results of such evaluation and   
include in each such report             
recommendations on-- 7#a7 addressing    
gaps in ,federal oversight of           
high-containment laboratories2 and  7#b7
 utilizing high-containment laboratories
 for protecting public health and       
ensuring biosecurity in the ,united     
,states4  7d7 ,public ,health and       
,biosecurity ,team  7#a7 ,in general    
,the ,federal official designated under 
subsection 7a7 shall maintain a team1 to
 be known as the ,public ,health and    
,biosecurity ,team1 to serve as a single
 point of contact for ,state and local  
agencies regarding questions of public  
health relating to laboratory biosafety 
and biosecurity4  7#b7 ,establishment   
,the ,federal official designated under 
subsection 7a7 shall establish the      

,public ,health and ,biosecurity ,team1 
as required by paragraph 7#a71 not later
 than one year after such official is   
first designated4  7#c7 ,duties ,the    
,public ,health and ,biosecurity ,team  
shall be the primary point of contact in
 the ,federal ,government for ,state and
 local agencies on--  7,a7 issues       
related to-- 7i7 oversight of           
high-containment laboratories2  7ii7 the
 impact of high-containment laboratories
 on public health2 or  7iii7 connecting 
,state and local officials with the     
relevant ,federal agency or agencies on 
matters related to high-containment     
laboratories2 and  7,b7 other issues as 
determined necessary by the ,federal    
official designated under subsection    
7a74  7e7 ,feasibility study  7#a7 ,in  
general ,the ,federal official          
designated under subsection 7a7 shall   
conduct a feasibility study on          
establishing and maintaining a database 
on existing high-containment            
laboratories in the ,united ,states and 

making such database accessible to      
,state and local officials4  7#b7       
,database described ,the database to be 
studied under paragraph 7#a7 should be  
designed to include1 with respect to    
each high-containment laboratory1 the   
following information3 7,a7 ,the        
identity of the owners of the           
laboratory4  7,b7 ,the status of any    
licensing or certification of the       
laboratory required under ,federal1     
,state1 or local law4  7,c7 ,any legal  
violations by1 and disciplinary action  
taken against1 the laboratory4  7#c7    
,report to ,congress ,upon completion of
 the feasibility study under this       
subsection1 the ,federal official       
designated under subsection 7a7 shall   
submit to the ,congress a report on the 
results of such study4  7f7 ,definition 
,in this section1 the term              
high-containment laboratory means       
laboratories that are suitable for      
biosafety level #c or biosafety level #d
 procedures as defined in the latest    

edition of ,biosafety in                
,microbiological and ,biomedical        
,laboratories published by the ,centers 
for ,disease ,control and ,prevention   
and the ,national ,institutes of ,health
 7or any successor to such publication74